TY - JOUR
T1 - HARMONISATION – A multimodal prospective study of vascular cognitive impairment in multi-ethnic Asians
T2 - Cohort profile, progress, current contributions, and future impact
AU - Lim, Mark J.H.
AU - Cheung, Carol Y.
AU - Chong, Joyce R.
AU - Chua, Jacqueline
AU - Hilal, Saima
AU - Lai, Mitchell K.P.
AU - Maier, Andrea B.
AU - Schmetterer, Leopold
AU - Tan, Boon Yeow
AU - Venketasubramanian, Narayanaswamy
AU - Wong, Tien Yin
AU - Xu, Xin
AU - Yeo, BT Thomas
AU - Zhou, Juan Helen
AU - Chen, Christopher L.H.
N1 - Publisher Copyright:
© The Author(s) 2025
PY - 2025/12
Y1 - 2025/12
N2 - Vascular cognitive impairment (VCI) describes cerebrovascular disease (CeVD)-associated cognitive disorders regardless of pathogenesis, ranging from a prodrome to dementia. Heterogeneity in the etiology and severity of CeVD, and significant co-occurrence with Alzheimer's disease (AD) pathology has hampered investigations. Research into VCI is especially relevant in Asia, where cognitive impairment and dementia, often due to VCI, grows due to rapidly aging populations and high prevalence of vascular risk factors. This manuscript reviewed the rationale, unique positioning, design, methodology, and findings from the HARMONISATION study, a prospective observational study of VCI and AD in multi-ethnic Asians. HARMONISATION aimed to discover and validate novel biomarkers as effective diagnostic and prognostic tools, and translate findings into improved patient care, disease management and treatment—utilizing comprehensive multimodal clinical, neuroimaging, retinal, and blood biomarker data to address critical research gaps such as the etiology and clinical importance of mixed dementia, relationships between AD and CeVD pathology, and challenges of heterogenous CeVD pathology. HARMONIZATION recruited and deeply phenotyped 700 older multi-ethnic Asians with no cognitive impairment, mild cognitive impairment, and dementia for up to 5 years of follow-up. It has yielded developments in biomarker identification, validation, interactions and analysis methods; disease mechanisms and progression; clinical prognostics for VCI and AD; improved patient care and management; and enabled future development of novel interventions in Asians, and globally. An ongoing extension study will allow up to 10 years follow-up to further explore specific modifiable processes of VCI and the contributions of vascular events to cognitive impairment.
AB - Vascular cognitive impairment (VCI) describes cerebrovascular disease (CeVD)-associated cognitive disorders regardless of pathogenesis, ranging from a prodrome to dementia. Heterogeneity in the etiology and severity of CeVD, and significant co-occurrence with Alzheimer's disease (AD) pathology has hampered investigations. Research into VCI is especially relevant in Asia, where cognitive impairment and dementia, often due to VCI, grows due to rapidly aging populations and high prevalence of vascular risk factors. This manuscript reviewed the rationale, unique positioning, design, methodology, and findings from the HARMONISATION study, a prospective observational study of VCI and AD in multi-ethnic Asians. HARMONISATION aimed to discover and validate novel biomarkers as effective diagnostic and prognostic tools, and translate findings into improved patient care, disease management and treatment—utilizing comprehensive multimodal clinical, neuroimaging, retinal, and blood biomarker data to address critical research gaps such as the etiology and clinical importance of mixed dementia, relationships between AD and CeVD pathology, and challenges of heterogenous CeVD pathology. HARMONIZATION recruited and deeply phenotyped 700 older multi-ethnic Asians with no cognitive impairment, mild cognitive impairment, and dementia for up to 5 years of follow-up. It has yielded developments in biomarker identification, validation, interactions and analysis methods; disease mechanisms and progression; clinical prognostics for VCI and AD; improved patient care and management; and enabled future development of novel interventions in Asians, and globally. An ongoing extension study will allow up to 10 years follow-up to further explore specific modifiable processes of VCI and the contributions of vascular events to cognitive impairment.
KW - Alzheimer's disease
KW - Asia
KW - biomarkers
KW - cerebrovascular diseases
KW - dementia
KW - mild cognitive impairment
KW - mixed dementias
KW - Southeast Asia
KW - vascular dementia
UR - https://www.scopus.com/pages/publications/105023169157
UR - https://www.scopus.com/inward/citedby.url?scp=105023169157&partnerID=8YFLogxK
U2 - 10.1177/13872877251389006
DO - 10.1177/13872877251389006
M3 - Review article
C2 - 41160443
AN - SCOPUS:105023169157
SN - 1387-2877
VL - 108
SP - 1452
EP - 1474
JO - Journal of Alzheimer's Disease
JF - Journal of Alzheimer's Disease
IS - 4
ER -